Drug maker tests heart safety of new medication in healthy volunteers
NCT ID NCT07214935
Summary
This study tested whether a single dose of the drug evobrutinib causes any unwanted changes in heart rhythm, specifically the QT interval on an ECG. It involved 36 healthy adult volunteers who received the drug, a placebo, and a control medication in a random order. The main goal was to gather safety data on how the drug affects the heart before testing it in people with diseases.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Nuvisan GmbH
Neu-Ulm, Germany
Conditions
Explore the condition pages connected to this study.